Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 401 | Legacy EJY Inc (ENJYQ) | OOTC | US | 2021-12-31 | 2 years ago | USD | 0.01 | 0.00 | 0.00% | 0.58 | 5,759.07% | Ungraded | 0.00 | 0.00% |
| 402 | BioNexus Gene Lab Corp (BGLC) | XNAS | MY | 2023-12-31 | 2 days ago | USD | 2.88 | 0.00 | 0.00% | 35.65 | 1,237.84% | Ungraded | 0.00 | 0.00% |
| 403 | CohBar Inc (CWBR) | OOTC | US | 2022-12-31 | 3 months ago | USD | 0.41 | 0.00 | 0.00% | 5.22 | 1,273.15% | Ungraded | 0.00 | 0.00% |
| 404 | Telesis Bio Inc (DNAY) | XNAS | US | 2021-12-31 | 2 years ago | USD | 1.30 | 0.00 | 0.00% | 2.31 | 177.64% | Ungraded | 0.00 | 0.00% |
| 405 | Ayala Pharmaceuticals Inc (AYLA) | XNAS | US | 2021-12-31 | 2 years ago | USD | 0.50 | 0.00 | 0.00% | 2.35 | 469.48% | Ungraded | 0.00 | 0.00% |
| 406 | Neumora Therapeutics Inc (NMRA) | XNAS | US | 2024-12-31 | 2 days ago | USD | 0.76 | 0.00 | 0.00% | 1.76 | 231.20% | Ungraded | 0.00 | 0.00% |
| 407 | Sino Assurance Inc (SNAS) | 2011-12-31 | 4 years ago | USD | 0.02 | 0.40 | 2,012.46% | 0.17 | 828.07% | Ungraded | 0.00 | 0.00% | ||
| 408 | MEI Pharma Inc (MEIP) | XNAS | US | 2024-06-30 | 2 days ago | USD | 2.10 | 0.00 | 0.00% | 4.87 | 231.73% | Ungraded | 0.00 | 0.00% |
| 409 | Bluejay Diagnostics Inc (BJDX) | XNAS | US | 2024-12-31 | 2 days ago | USD | 1.67 | 0.00 | 0.00% | 7.22 | 432.23% | Ungraded | 0.00 | 0.00% |
| 410 | Vyne Therapeutics Inc (VYNE) | XNAS | US | 2024-12-31 | 2 days ago | USD | 1.43 | 0.00 | 0.00% | 3.35 | 233.98% | Ungraded | 0.00 | 0.00% |